Alternate Name:Pharmapure RX Esomep-EZS
Description:Nexium treats gastroesophageal reflux disease (GERD), esophagitis, and stomach ulcers. The generic version of Nexium is esomeprazole magnesium. For a supply of 30 oral tablets of Nexium Delayed-Release Capsules 40 mg is approximately $287. Take advantage of our LowerMyRx discount to receive a typical Nexium discount of up to 80% off of the retail price at participating pharmacies near you.
Dosage Form:Capsule Delayed Release
Administration Route:By mouth
Drug Class:Gastric Acid Secretion Inhibitor, Gastrointestinal Agent
Generic Available:Yes
Strength:20 MG
Warnings:Tell your doctor if you are pregnant or breastfeeding, or if you have kidney disease, liver disease, lupus, vitamin B12 deficiency, or osteoporosis. This medicine may cause the following problems: Kidney problems, including acute tubulointerstitial nephritisIncreased risk of broken bones in the hip, wrist, or spine (more likely if used several times per day or longer than 1 year)Serious skin reactions, including Stevens-Johnson syndrome, toxic epidermal necrolysis, acute generalized exanthematous pustulosis, and drug reaction with eosinophilia and systemic symptoms (DRESS)LupusFundic gland polyps (abnormal growth in the upper part of your stomach) This medicine can cause diarrhea. Call your doctor if the diarrhea becomes severe, does not stop, or is bloody. Do not take any medicine to stop diarrhea until you have talked to your doctor. Diarrhea can occur 2 months or more after you stop taking this medicine. Tell any doctor or dentist who treats you that you are using this medicine. This medicine may affect certain medical test results. Your doctor will do lab tests at regular visits to check on the effects of this medicine. Keep all appointments. Keep all medicine out of the reach of children. Never share your medicine with anyone. Stomach pain, nausea, vomiting, weight loss, bloody or black stools
Food Warnings:Do not use esomeprazole if you are also using medicines that contain rilpivirine., Some medicines can affect how esomeprazole works. Tell your doctor if you are using any of the following: Atazanavir, cilostazol, diazepam, digoxin, erlotinib, ketoconazole, methotrexate, mycophenolate mofetil, nelfinavir, rifampin, saquinavir, St John's wort, tacrolimus, voriconazoleBlood thinner (including clopidogrel or warfarin)Diuretic (water pill)Iron supplements, This medicine can cause diarrhea. Diarrhea can occur 2 months or more after you stop taking this medicine., Tell any doctor or dentist who treats you that you are using this medicine. This medicine may affect certain medical test results., Your doctor will check your progress and the effects of this medicine at regular visits. Keep all appointments., Keep all medicine out of the reach of children.
In re rilapir (Rilac). In re rilapir/ritapir, as an alternative to esomeprazole, as an oral solution for the treatment of reflux disease, upper stomach ulcers, reflux disease, esophagitis, GERD, post-prandial hypertension, post-operative pain, post-surgical pain, post-operative pain, proton pump disorder, and acute pain in the upper stomach. Dapoxetine as an oral tablet. Take one tablet once a day. The duration of treatment will depend on the nature and severity of the symptoms. It is not expected that a missed dose will cause a problem for you.This medication may cause the following problems.
Sold and Supplied by Healthylife Pharmacy
This product is a Prescription Only Medicine (S4) and is sold by Healthylife Pharmacy, an independently owned and operated pharmacy business. This prescription product requires a valid Australian script.
Medicare CardNo MedicareConcession
$35.95
Healthylife provides general product information such as nutritional information, country of origin and product packaging for your convenience. This information is intended as a guide only, including because products change from time to time. Please read product labels before consuming. For therapeutic goods, always read the label and follow the directions for use on pack. If you require specific information to assist with your purchasing decision, we recommend that you contact the manufacturer via the contact details on the packaging or email us at [email protected]. Product ratings and reviews are taken from various sources including Bazaarvoice. Healthylife does not represent or warrant the accuracy of any statements, claims or opinions made in product ratings and reviews.
Keep out of the reach of childrenBeware of products containing display signsHealthylife.com.au provides a review and list of unlisted medicines. This product does not carry theACHOTHER sign or mentionvantHealthylife provides a list of unlisted medicines.
Product variants
Nexium 24HR Once Daily Dosing Tablets provide lasting relief from frequent heartburn and acid reflux.
Nexium 24HR 20mg esomeprazole tablets are for the lasting symptomatic relief of frequent heartburn, acid regurgitation and other symptoms associated with gastro-oesophageal reflux
Carefully read the enclosed Consumer Medicine Information before use.
AUST R NUMBER:231439
Lactose
INGREDIENTS:Each tablet contains: Esomeprazole 20mg (as Magnesium Trihydrate).
Do not use:- for children under 18 years of age.- if allergic to esomeprazole.- if allergic to any other proton pump inhibitor (omeprazole, rabeprazole, lansoprazole, pantoprazole).- if you are taking antiretroviral medicines, such as atazanavir.- if you are taking cilostazol a medicine used to treat pain and/or cramping in the lower leg (or arms) due to inadequate blood flow to the muscles.- if you are breastfeeding or intend to breastfeed.- -f you are experiencing weight loss, persistent regurgitation of food or vomiting, difficulty swallowing or symptoms of gastro-intestinal bleeding, except on medical advice- if you are pregnant or intend to become pregnant except on the advice of a doctor or pharmacist- if the expiry date printed on the pack has passed. Ask your pharmacist or doctor before use if you:- have or ever have had serious liver disease.- are taking digoxin (a medicine used to treat heart problems).- are taking ketoconazole (a medicine used to treat fungal infections)- are taking clopidogrel or warfarin (medicines used to stop the blood clotting)- are taking other medicines regularlyThis preparation is for the relief of minor and temporary ailments and should be used strictly as directed. Do not use for any purpose other than what is specified on the pack, except on doctor's advice. Keep to recommended dose. If an overdose is taken or suspected telephone your doctor or the Poisons Information Centre (Australia 13 11 26, or New Zealand 0800 764 766) or go to the Accident and Emergency department at your nearest hospital. Tell your pharmacist or doctor if you do not feel well, if new or additional symptoms occur while you are taking Nexium 24HR Once Daily Dosing.
ONLINE MANDATORY STATEMENT:Always read the label and follow the directions for use.
Puerto Rico, US
AlliSildenafil ReviewsEsomeprazole
Do not use:- for children under 18 years of age.- if allergic to esomeprazole.- if allergic to any other proton pump inhibitor (omeprazole, rabeprazole, lansoprazole, pantoprazole).- if you are taking antiretroviral medicines, such as atazanavir.- if you are taking cilostazol a medicine used to treat pain and/or cramping in lower leg (or arms) due to inadequate blood flow to the muscles.- if you are taking ciprofloxacin (Cilastatin, in tablet form)- if you are taking ketoconazole (a medicine used to treat fungal infections)- if you are taking indinavir (an oral antiviral medicine)- if you are taking the capsules of the macapoon Drug Information
Adults and children over 18 years: Take one tablet daily for at least 7 days and up to 14 days.
Children under 14 years: Swallow the tablet whole with water after itching or burning.Details
Nexium Control provides a course of treatment for relieving symptoms of heartburn, indigestion, and acid reflux. Each pack contains 7 tablets intended for short-term use. These tablets work by reducing stomach acid production, thereby managing discomfort associated with digestive acid-related conditions. It's important to follow the instructions provided for optimal results. GlaxoSmithKline (UK) Trading Limited GSK Consumer Healthcare (IE) Ltd., 980 Great West Road, Brentford, TW8 9GS, U. K. Or: 12 Riverwalk, Citywest Business Campus, Dublin 24, Ireland.
Show more
Ingredients
Ingredients: Each Gastro-Resistant Tablet contains 20 mg Esomeprazole (as Magnesium Trihydrate). Contains sucrose. See package leaflet for further information. As we are always looking to improve our products, our formulations change from time to time, so please always check the packaging before use.
Directions
Directions for use: Take one tablet once a day. Do not exceed this dose. The tablets should be swallowed whole. Do not chew or crush the tablets. May take 2-3 days for full effect. If your symptoms worsen or do not improve after taking this medicine for 14 days in a row, contact your doctor. Read the package leaflet before use. Oral use. Storage recommendation: Do not store above 30°C. Store in the original package in order to protect from moisture. Keep out of the sight and reach of children.
How it worksMore ways to order than by boxMore options than by boxesMore options than than thanby boxes
than any other brand
NEXTmu tablets are manufactured in a facility at Brentford Road, and are available to order through GlaxoSmithKline, Consumer Healthcare (IE) Ltd., GSK (GMC), or their equivalent. Each batch of 21 tablets available in batch has been approved by the U. S. Food and Drug Administration (FDA) to be used for the treatment of gastro-resistant topically-induced gastric pH changes.
A $20-million rebate for the drug, Nexium, was reportedly awarded for the drug’s failure to deliver the expected results in the second quarter. The money was awarded for a total of $1.4 million, or $908,000. The total was also awarded to a total of $7,000,000, which was for a six-month supply of the drug. The total was also awarded to a total of $3,250,000, which was for a six-month supply of the drug. In the first quarter, Nexium was the drug’s second-biggest selling drug. The drug, manufactured by Novo Nordisk, was the second-best seller for $3.5 million in the third quarter. In the fourth quarter, Nexium was the drug’s third-best seller, with sales of $3.1 million, or $3.5 million, in the quarter ended June 30, 2019. The drug, also manufactured by Novo Nordisk, was the drug’s fifth-best seller, with $2.3 million, or $2.7 million. Novo Nordisk had a sales target of $1.1 billion in the quarter and the company had a target of $1.7 billion in the fourth quarter. The company’s total net income for the quarter was $4.5 million, or $2.2 million, compared with a net loss of $2.2 million in the quarter last year. The drug’s revenue was $7.1 million, or $5.1 million, compared with a revenue of $6.8 million, or $6 million, in the quarter last year. The drug’s sales were $2.2 million, or $1.4 million, compared with a revenue of $2.5 million, or $1.5 million, in the quarter last year. Net income for the quarter was $4.5 million, or $2.2 million. The drug’s net income for the quarter was $6.6 million, or $5.1 million, compared with a net loss of $4.4 million, or $4.4 million, in the quarter last year. The drug’s sales were $3.5 million, or $2.5 million, compared with a revenue of $3.9 million, or $3.8 million, in the quarter last year. Sales of the drug’s top seller were $5.3 million, or $2.4 million, compared with a revenue of $4.3 million, or $4.3 million, in the quarter last year. Sales of Nexium’s top seller were $5.3 million, or $2.6 million, compared with a revenue of $4.3 million, or $4.3 million, in the quarter last year. Sales of the drug’s other top sellers were $4.3 million, or $2.6 million, compared with a revenue of $4.3 million, or $4.3 million, in the quarter last year. Net income for the quarter was $7.5 million, or $5.3 million, compared with a revenue of $7.9 million, or $7.6 million, in the quarter last year. The drug’s net income for the quarter was $8.2 million, or $5.3 million, compared with a revenue of $8.5 million, or $6.8 million, in the quarter last year. The drug’s sales were $7.5 million, or $5.3 million, compared with a revenue of $8.9 million, or $8.8 million, in the quarter last year. Sales of the drug’s other top sellers were $8.5 million, or $5.3 million, compared with a revenue of $8.9 million, or $9.5 million, in the quarter last year. Sales of the drug’s top seller were $9.5 million, or $5.3 million, compared with a revenue of $9.5 million, or $8.8 million, in the quarter last year. Sales of the drug’s top seller were $10.5 million, or $5.3 million, compared with a revenue of $10.5 million, or $8.8 million, in the quarter last year. Sales of the drug’s other top sellers were $11.5 million, or $5.3 million, compared with a revenue of $11.5 million, or $7.5 million, in the quarter last year. Sales of Nexium’s top seller were $11.5 million, or $5.3 million, compared with a revenue of $11.5 million, or $7.